Sentence examples for trial in question from inspiring English sources

Such lapses not only impair the integrity of the trial in question.

The Celexa trial in question was run in Europe from 1996 to 2002 and was sponsored by H. Lundbeck, the Danish company that developed the drug.

With the evidence files destroyed and a trial in question, it is unlikely that the full story of the Tinners will be told any time soon.

You could call it groundbreaking, though not without some qualification: cameras have been permitted in Scottish courts since 1992, provided the participants give consent; the trial in question was concluded over a year ago, its outcome a matter of public record; six weeks of filming was boiled down to two hours of TV, and even that included archive footage and interviews with participants.

HPTN052, as the trial in question is known, points the way.What HPTN052 shows is that the drug treatment used to prolong the lives of those infected with HIV, by stopping the virus reproducing in their bodies, can also stop the virus's transmission.

Evidence of that is not so much that the trial in question was that of the prime minister himself, Silvio Berlusconi, who is accused of bribing judges, as that his efforts to move it were made under a law pushed through parliament last November by his own government.

The clinical trials in question all used the anemia drugs to raise patients' red blood cell levels more than what is recommended in the drugs' labels.

GSK has not merely denied the charges: it has published data from the trials in question on its website, and it is now planning to introduce a policy of releasing to the public the results of all its clinical trials.As with his lawsuits against Wall Street and the mutual-fund industry, Mr Spitzer has shed light on questionable practices in an industry that had regarded them as normal.

In fact, most diabetes events in the trials in question relied on physicians' adverse event reports, which are often underreported.

Just one of the outlier trials in question had a significant result, and the weight that each these trials contributed to the pooled effect estimate was extremely low (< 1.5%).

The two trials in question no longer satisfy either requirement, as there is clearly a strong possibility that the drugs will have exactly the opposite effect on CVD to that intended.